February 13, 2024 Comments Off on New patent for Eli Lilly drug MOUNJARO Posted in: Patent Added Annual Drug Patent Expirations for MOUNJARO Mounjaro is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
The post New patent for Eli Lilly drug MOUNJARO appeared first on DrugPatentWatch – Ma…
February 13, 2024 Comments Off on New patent for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF Posted in: Patent Added Annual Drug Patent Expirations for FLONASE+SENSIMIST+ALLERGY+RELIEF Flonase Sensimist Allergy Relief is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from two suppliers. There…
The post New patent for Glaxosmithkli…